OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

ZEALAND PHARMA A/S DK 1/  DK0060257814  /

München
17/05/2024  18:04:11 Chg. -6.20 Volume Bid21:58:00 Ask21:58:00 High Low
81.35EUR -7.08% 171
Turnover: 13,864.95		 -Bid Size: - -Ask Size: - 83.50 80.45
GlobeNewswire 16/05 Zealand Pharma Announces Financial Results for the First Quarter of 2024
GlobeNewswire 09/05 Zealand Pharma conference call on May 16 at 2pm CET (8am ET) to present first quarter 2024 financial...
GlobeNewswire 20/03 Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatm...
GlobeNewswire 01/03 Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference
GlobeNewswire 27/02 Zealand Pharma Announces Financial Results for the Full Year 2023
TeleTrader 26/02 Zealand Pharma soars 30% on positive weight-loss drug results
GlobeNewswire 26/02 Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated ...
GlobeNewswire 26/02 Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver dise...
GlobeNewswire 20/02 Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financia...
GlobeNewswire 19/01 Zealand Pharma major shareholder announcement: J O Hambro Capital Management
GlobeNewswire 17/01 Zealand Pharma major shareholder announcement: J O Hambro Capital Management
GlobeNewswire 12/01 Zealand Pharma completes registration of capital increase
GlobeNewswire 10/01 Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC
GlobeNewswire 08/01 Zealand Pharma announces directed issue and private placement for gross proceeds of DKK 1.45 billion
GlobeNewswire 02/01 Zealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on Janua...
GlobeNewswire 23/12/2023 U.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital hyp...
GlobeNewswire 22/12/2023 Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndrome
GlobeNewswire 22/12/2023 Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank
GlobeNewswire 04/12/2023 Zealand Pharma to highlight obesity pipeline at R&D Event on December 5
GlobeNewswire 30/11/2023 Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers
GlobeNewswire 09/11/2023 Zealand Pharma Announces Financial Results for the First Nine Months of 2023
GlobeNewswire 07/11/2023 Zealand Pharma to participate in the Jefferies London Healthcare Conference in November 2023
GlobeNewswire 03/11/2023 Zealand Pharma conference call on November 9 at 2pm CET (8am ET) to present third quarter 2023 resul...
GlobeNewswire 17/10/2023 Zealand Pharma presents data for amylin analog ZP8396 at ObesityWeek
GlobeNewswire 05/10/2023 Phase III studies to investigate survodutide for people living with obesity and overweight, with and...